{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:07:38Z","timestamp":1781089658574,"version":"3.54.1"},"reference-count":47,"publisher":"Informa UK Limited","issue":"1-2","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"\u2018Current Research Annual Funding\u2019 of the Italian Ministry of Health"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Emerging Drugs"],"published-print":{"date-parts":[[2026,4,3]]},"DOI":"10.1080\/14728214.2026.2675274","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T08:40:36Z","timestamp":1779180036000},"page":"29-36","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Potassium channel agonists emerging as treatment options for focal epilepsy: are we breaking new ground?"],"prefix":"10.1080","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3610-5819","authenticated-orcid":false,"given":"Cristiana","family":"Pelorosso","sequence":"first","affiliation":[{"name":"Meyer Children\u2019s Hospital IRCCS","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Balestrini","sequence":"additional","affiliation":[{"name":"Meyer Children\u2019s Hospital IRCCS","place":["Florence, Italy"]},{"name":"University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Guerrini","sequence":"additional","affiliation":[{"name":"Meyer Children\u2019s Hospital IRCCS","place":["Florence, Italy"]},{"name":"University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/EPD2.20045"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/EPI4.12845"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1113\/JPHYSIOL.2010.191973"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/J.1528-1167.2009.02397.X"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70153-9"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.107966"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(11)70047-3"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2011.01.004"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1499-1654.2000.001597.x"},{"key":"e_1_3_3_12_1","unstructured":"Grand View Research. Epilepsy drug market (2025\u20132030). 2025 [cited 2026 Mar 24]. Available from: https:\/\/www.grandviewresearch.com\/industry-analysis\/epilepsy-drugs-market"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.70530"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/NRN1785"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1073\/PNAS.0802805105"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1073\/PNAS.1216867110"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/EPI.17239"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI.INSIGHT.156314"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11671"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000259034.45049.00"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0B013E3181FD6170"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0B013E3182194BD3"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2014.08.001"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2017.06.018"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/JAMADERMATOL.2013.8895"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1021\/ACS.CHEMRESTOX.8B00313"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/CMDC.202200262"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/JAMANEUROL.2023.3542"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/EPI.18056"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/S40263-024-01155-3"},{"key":"e_1_3_3_31_1","unstructured":"Xenon Pharmaceuticals Inc. Xenon announces positive topline data from phase 3 X-TOLE2 study of azetukalner in focal onset seizures (FOS). 2026 [cited 2026 Mar 24]. Available from: https:\/\/investor.xenon-pharma.com\/news-releases\/news-release-details\/xenon-announces-positive-topline-data-phase-3-x-tole2-study"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/JAMANETWORKOPEN.2025.14278"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000206409"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000206367"},{"key":"e_1_3_3_35_1","unstructured":"Biohaven Ltd. Biohaven provides update from phase 2 proof-of-concept study with BHV-7000 in major depressive disorder. 2025 [cited 2026 Mar 24]. Available from: https:\/\/ir.biohaven.com\/news-releases\/news-release-details\/biohaven-provides-update-phase-2-proof-concept-study-bhv-7000"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1021\/ACS.JMEDCHEM.0C02252"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/CNS.70002"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/EPI.17884"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2025.110658"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/EPI.16932"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/CMDC.201900112"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1021\/ACS.JMEDCHEM.2C00911"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.174935"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/S00406-022-01532-3"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/J.PAIN.0000000000003390"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/BPH.70119"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/JAT.2916"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2012.02.007"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881111415733"}],"container-title":["Expert Opinion on Emerging Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14728214.2026.2675274","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:33:36Z","timestamp":1781087616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14728214.2026.2675274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":47,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2026,4,3]]}},"alternative-id":["10.1080\/14728214.2026.2675274"],"URL":"https:\/\/doi.org\/10.1080\/14728214.2026.2675274","relation":{},"ISSN":["1472-8214","1744-7623"],"issn-type":[{"value":"1472-8214","type":"print"},{"value":"1744-7623","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-01-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}